USPTO serial 79308437
COCHLEAR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 26, 2022
- Examiner
- FRENCH, CURTIS W
- Law office
- TMO LAW OFFICE 115
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with COCHLEAR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jason Vogel
Jason Vogel KILPATRICK TOWNSEND & STOCKTON LLP1100 Peachtree Street, Suite 2800MAILSTOP: IP DOCKETING - 22Atlanta, GA 30309-4528Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of inflammation or fibrosis, the preservation or improvement of neural structures or functions, or the inhibition of osteoneogenesis; medical preparations for the treatment of inflammation or fibrosis, the preservation or improvement of neural structures or functions, or the inhibition of osteoneogenesis; pharmaceutical drugs for the treatment of inflammation or fibrosis, the preservation or improvement of neural structures or functions, or the inhibition of osteoneogenesis; corticosteroids; dexamethasone; anti-inflammatory, anti-fibrotic, anti-apoptotic, anti-oxidant, immunosuppressing, neuroprotective, neurotrophic and neuroregenerative drugs; pharmaceutical sprays for the body for the treatment of inflammation or fibrosis, the preservation or improvement of neural structures or functions, or the inhibition of osteoneogenesis; [ medical disinfectants; antiseptics; ] disinfectant medicated cleaning preparations for instruments; chemical reagents for medical purposes; chemical preparations for medical purposes, namely, for the treatment of inflammation or fibrosis, the preservation or improvement of neural structures or functions, or the inhibition of osteoneogenesis * ; all of the aforesaid excluding medical disinfectants * | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 7, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 29, 2025 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Aug 12, 2024 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Aug 5, 2024 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 9, 2024 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Dec 4, 2023 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Dec 4, 2023 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Nov 5, 2023 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Sep 26, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 5, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 5, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 14, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 26, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 26, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 8, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 8, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 6, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 19, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 19, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 19, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 4, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 14, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 13, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 13, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 5, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 11, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 11, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 8, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 7, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 3, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 13, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 9, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 8, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |